Korro Bio
KRRO
51 hedge funds and large institutions have $225M invested in Korro Bio in 2020 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 17 increasing their positions, 17 reducing their positions, and 8 closing their positions.
6% more capital invested
Capital invested by funds: $213M → $225M (+$12.1M)
0.01% more ownership
Funds ownership: 0.81% → 0.82% (+0.01%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 8
0% more repeat investments, than reductions
Existing positions increased: 17 | Existing positions reduced: 17
2% less funds holding
Funds holding: 52 → 51 (-1)
Top Buyers
Top Sellers
| 1 |
DM
Deerfield Management
New York
|
-$10.2M |
| 2 |
BlackRock
New York
|
-$2.85M |
| 3 |
Millennium Management
New York
|
-$2.47M |
| 4 |
LCM
Laurion Capital Management
New York
|
-$2.26M |
| 5 |
GIM
Granahan Investment Management
Waltham,
Massachusetts
|
-$1.25M |
KRRO Hedge Fund Activity: Q1 2020 in Review
51 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in Korro Bio (KRRO) for Q1 2020, worth a combined $225M — up 5.7% from $213M a quarter earlier.
Fund positioning in KRRO was balanced in Q1 2020: 8 funds opened new positions, 8 closed out, 17 added to existing stakes and 17 trimmed.
The largest buyer was RTW Investments, adding an estimated $16.6M. The largest seller was Deerfield Management, cutting an estimated $10.2M.
- 51 institutional investors held Korro Bio (KRRO) as of Q1 2020, down from 52 in Q4 2019.
- Funds reported $225M of Korro Bio stock for Q1 2020, up 5.7% quarter-over-quarter.
- 8 funds opened new Korro Bio positions in Q1 2020 and 8 closed out, a net change of 0 holders.
- The largest Korro Bio buyer in Q1 2020 was RTW Investments, an estimated $16.6M added.
- The largest Korro Bio seller in Q1 2020 was Deerfield Management, an estimated $10.2M sold.
Based on aggregated 13F filings for Q1 2020.